Sign Up Now to Download a Free Research Report on CYCC

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts





Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals shares declined 13.54 percent on volume of 2.58 million shares traded to close at $3.00 a share. The company announced the pricing of an underwritten offering of 6,666,667 shares of its common stock at $3.00 per share.

Going forward ... (see research report)



RESEARCH REPORT ON CYCC Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on